IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Accrued Liabilities Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Accrued Liabilities
kr14.9m
CAGR 3-Years
8%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Accrued Liabilities
kr252.1m
CAGR 3-Years
67%
CAGR 5-Years
106%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Accrued Liabilities
kr233.8m
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Accrued Liabilities
kr78.5m
CAGR 3-Years
53%
CAGR 5-Years
94%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Accrued Liabilities
kr9.2m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Accrued Liabilities
kr19.3m
CAGR 3-Years
79%
CAGR 5-Years
11%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Accrued Liabilities?
Accrued Liabilities
14.9m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Accrued Liabilities amounts to 14.9m SEK.

What is IRLAB Therapeutics AB's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
38%

Over the last year, the Accrued Liabilities growth was 11%. The average annual Accrued Liabilities growth rates for IRLAB Therapeutics AB have been 8% over the past three years , 38% over the past five years .

Back to Top